FDA Considers Tougher Advisory on Meridia

Looks like another one of the toxic drugs my hero Dr. David Graham "outed" during his testimony at a Senate Finance Committee meeting late last year -- the "anti-obesity" drug Meridia -- will receive a tougher advisory from the FDA very soon.

Although the FDA stands by the drug (far more supportive today than the ruling from an advisory committee in 1996 who voted 5-4 against its approval), the Chicago Tribune cited a source close to the agency who expects it to issue a tougher stance that could result in anything from updated guidelines to restricting its use.

A neurotransmitter reuptake inhibitor that works by affecting the natural chemicals in the brain involved in regulating appetite, Meridia has been found to cause substantial increases in blood pressure and has been associated with 124 reports of serious cardiovascular problems, just two of the many side effects that forced Italian regulators to pull the drug off the market three years ago.

  • Abdominal pain
  • Acid indigestion
  • Anxiety
  • Back pain
  • Constipation

And all because people prefer "quick fix" solutions to their problems that could be far more fatal to them -- and line the pockets of greedy drug companies all too happy to provide them -- than simpler, healthier treatments you can start today:

Chicago Tribune March 13, 2005 registration required

Kansas City Star March 13, 2005

Click Here and be the first to comment on this article
Post your comment